ArticleMembranes2022
Enhancing Performance of Thin-Film Nanocomposite Membranes by Embedding in Situ Silica Nanoparticles.
Article in Membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
In this work, silica nanoparticles were produced in situ, to be embedded eventually in the polyamide layer formed during interfacial polymerization for fabricating thin-film nanocomposite membranes with enhanced performance for dehydrating isopropanol solution. The nanoparticles were synthesized through a sol-gel reaction between 3-aminopropyltrimethoxysilane (APTMOS) and 1,3-cyclohexanediamine (CHDA). Two monomers-CHDA (with APTMOS) and trimesoyl chloride-were reacted on a hydrolyzed polyacrylonitrile (hPAN) support. To obtain optimum fabricating conditions, the ratio of APTMOS to CHDA and reaction time were varied. Field emission scanning electron microscopy (FESEM) and atomic force microscopy (AFM) were used to illustrate the change in morphology as a result of embedding silica nanoparticles. The optimal conditions for preparing the nanocomposite membrane turned out to be 0.15 (g/g) APTMOS/CHDA and 60 min mixing of APTMOS and CHDA, leading to the following membrane performance: flux = 1071 ± 79 g∙m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.